Navigation Links
Herr receives Heinz Award for Technology, the Economy and Employment
Date:9/12/2007

hode Island VA Medical Center. The effort focuses on developing new technologies for amputees, specifically biohybrid limbs comprised of regenerated tissue, lengthened bone, titanium bone implants, implantable neural sensors and external robotic limbs.

The subject of a Discovery Channel movie in 2002, Dr. Herr is very involved in sporting activities, including No Barriers USA, which promotes the advancement of new technologies and techniques to improve the quality of life of physically challenged people.

The nature of my work has been incredibly gratifying, not only by virtue of the impact it has on those of us with physical challenges, but also for its potential impact on the larger population as a whole, Dr. Herr said. This field is still in its infancy, and I have great hope that it can be applied to a broad range of utility to make healthy bodies better and stronger, to create new forms of mobility and to expand our capacity to perform beyond human limits. My thanks go out to the Heinz Family Foundation for recognizing me and by extension my many colleagues over the years with this magnificent honor.

Since 1993, the Heinz Family Foundation of Pittsburgh has recognized individuals whose dedication, skill and generosity of spirit represent the best of the human qualities that the late Sen. Heinz, for whom the award is named, held so dear.

Presented in five categories, the other Heinz Award recipients are:

  • Arts and Humanities: Dave Eggers, San Francisco, author and founder of the 826 Valencia writing laboratories as well as a publishing house for emerging writers
  • Environment (co-recipients): Bernard Amadei, Ph.D., Boulder, Colo., engineer, professor and founder of Engineers without Borders - USA; and Susan Seacrest, Lincoln, Neb., environmental advocate and founder of the Groundwater Foundation
  • Human Condition: David L. Heymann, M.D., Geneva, Switzerland, physician, an
    '/>"/>

Contact: Jon Newman
jnewman@hodgespart.com
804-788-1414
The Heinz Family Foundation
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. DuPonts first biologically derived polymer receives global recognition
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Research on antibiotics receives historical recognition
4. Anthrax test, developed by army and CDC, receives FDA approval
5. Research team receives $7.5 million to study cassava
6. NJIT Presidential Award winner takes stem cell research another step
7. TGen awarded $7.1 million to accelerate brain disease research
8. Virtual microscopy project wins educational technology award
9. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
10. Long-lived deep-sea fishes imperiled by technology, overfishing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...y of West African chimpanzees living in Cte d,Ivoi...pecies has dropped in numbers by a whopping 90 per...ago. The few remaining chimpanzees are now highly ... in Ta National Park, according to a report in the...ress publication. , This alarming decline in a c...
(Date:10/13/2008)... reveal why different parts of the brain can come ...MS). According to a new study in mice with an MS-l...duced by invading T cells dictates whether it,s th... The studyfrom researchers at the University of Ma...ton University in St. Louiswill be published onlin...
(Date:10/12/2008)...o available in French . , Researchers at McGi...hKline Inc. have identified two genetic variants i...evenfold increase the risk of male pattern baldnes...journal Nature Genetics. , About a third of al... 45. The condition,s social and economic impact is...
(Date:10/10/2008)... -- In a groundbreaking study led by an eminent mo...earchers have discovered that as embryonic stem ce...atic corresponding changes to the order in which D... bridge a critical knowledge gap for stem cell bio...ormously complex process by which DNA is repackage...
Breaking Biology News(10 mins):In a last 'stronghold' for endangered chimpanzees, survey finds drastic decline 2Researchers discover baldness gene: 1 in 7 men at risk 2Landmark study unlocks stem cell, DNA secrets to speed therapies 2Landmark study unlocks stem cell, DNA secrets to speed therapies 3Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results 15714 1Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 1Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 2Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 3MiMedx Group Announces Post split Name Change 4339 1MiMedx Group Announces Post split Name Change 4339 2MiMedx Group Announces Post split Name Change 4339 3Restrictive Prescription Drug Policies Hurt Schizophrenics 15708 1Restrictive Prescription Drug Policies Hurt Schizophrenics 15708 2
...minated this week by the continuing debate over HI...mang repeated yet again that drugs were not the on...ere also important. , After previously denying li...ment began providing AIDS drugs in clinics last ye... positive, which is more than any other nationalit...
...noma, studying functional tissue rather than cell ...s development, according to new research from a Ho...t Stanford University School of Medicine. , Though...melanoma development, scientists have not been abl...alterations and human cancer growth. Determining w...
...noma, studying functional tissue rather than cell ...s development, according to new research from a Ho...t Stanford University School of Medicine. , Though...melanoma development, scientists have not been abl...alterations and human cancer growth. Determining w...
...tistically significant improvements in clinical me...sia on the Etiology, Pathogenesis and Treatment of...eurologix,s Phase I trial showed positive interim ... year following treatment, patients exhibited a st...ion on the side of their body correlating to the t...
Other Biology News:Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 2Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 3Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack 2Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 2Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 4Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 5Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 6
(Date:10/14/2008)... China, Oct. 14 /Xinhua--,C...ina-Biotics", "the,Company"), a leading Chinese fi...lopment, marketing and distribution of probiotics ... to list its common stock on the,Nasdaq Global Mar...he Nasdaq on October 23,2008, until which time it...
(Date:10/14/2008)... Va., Oct. 14 /- Insmed Inc...ogics and biopharmaceuticals, today,announced that...reverse,stock split, if necessary, at a Special Me...effort to meet the minimum bid price rule for cont...tember 3, 2008, the Company announced that the NAS...
(Date:10/14/2008)... China, Oct. 14 /Xinhua-- WuXi Pharma...eutical, biotechnology and,medical device research...ns,in China and the United States, today announced...for the third quarter ended September 30, 2008,an...Logo: http://www.newscom.com/cgi-bin/prnh/2004070...
(Date:10/13/2008)...ES, Oct. 13 /- Vista Partners announc...can Bio Medica Corporation,(Nasdaq: ABMC ) and ma...ss,Silver, Director of Research at Vista Partners ...e and sales from the Company,s lab,alliance, which... centers,continue to increase as well. The Compan...
Breaking Biology Technology:China-Biotics, Inc. Approved to List on the Nasdaq Global Market 2Insmed to Seek Shareholder Approval for Reverse Split 2Insmed to Seek Shareholder Approval for Reverse Split 3WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 2WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 3WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 4WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 5WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 6WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 7WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 8Vista Partners Updates Coverage; Maintains $3.20 Target Price 2
...ulk and custom kits made-to-order , Cust... Stringent quality control guaranteed , ... , Ambion Custom has a staff of R&D and ... plan your research and design products specifical...oduct can be customized. You specify the volumes a...
...lencer Validated siRNAs are single siRNA duplexes ...-PCR to reduce the expression of a number of impor... validation is a >70% reduction in , targ...ugh the average , reduction in target gen... , is greater than 90%. Every Silencer Va...
... , , , Application Gu........................................................on .................................................................................2 , II. P........................................................
...lication Guide, ,I. Description ,II. Prod...by the User ,IV. Protocol for Extraction of DN...Genome Amplification from Soil ,VI. Quantifica...of Amplified Products , ,Appendix, , R...,Application Guide, , I. Description ,T...
Other Biology Technology:Ambion Custom: Made-to-Order 2Ambion Custom: Made-to-Order 3Silencer Validated siRNAs 2Silencer Validated siRNAs 3Silencer Validated siRNAs 4Silencer Validated siRNAs 5Silencer Validated siRNAs 6Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 2Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 3Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 4Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 5Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 6Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 7Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 8Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 9Protocol for GenomePlex Whole Genome Amplification from Soil 2Protocol for GenomePlex Whole Genome Amplification from Soil 3Protocol for GenomePlex Whole Genome Amplification from Soil 4Protocol for GenomePlex Whole Genome Amplification from Soil 5
capacity 250 mL
Rabbit polyclonal to MSY2/YBOX2 ( Abpromise for all tested applications). Antigen: Synthetic peptide derived from a region between amino acids 178-227 of human YBX2. (Note: the exact amino acid
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z35,347-7) or contact custom
Standard Fluka For microscopy (Bact., Hist.)
Biology Products: